EyePoint Pharmaceuticals Inc.

NAS: EYPT

GO
/marketstate/country/us

Market open

 --Real time quotes

Sep 22, 2023, 2:56 p.m.

/zigman2/quotes/210537129/composite

$

8.49

Change

+0.14 +1.62%

Volume

Volume 353,252

Real time quotes

/zigman2/quotes/210537129/composite

Previous close

$ 8.35

$ 8.49

Change

+0.14 +1.62%

Day low

Day high

$8.35

$8.87

Open

52 week low

52 week high

$2.19

$15.63

Open

Jay S. Duker

Jay S. Duker founded Hemera Biosciences, Inc. Currently, Dr. Duker is President, Chief Executive Officer & Director at EyePoint Pharmaceuticals, Inc. Dr. Duker is also on the board of Hemera Biosciences, Inc.

Dr. Duker previously was Chairman for Sesen Bio, Inc., Professor & Chairman-Ophthalmology Department at Tufts Medical Center, Inc. and Chairman-Ophthalmology & Professor at Tufts University School of Medicine.

Dr. Duker received a doctorate from Sidney Kimmel Medical College and an undergraduate degree from Harvard University.

Transactions

Date Shares Transaction Value
06/21/2019 6,667   Derivative/Non-derivative trans. at $0 per share. 0
04/12/2019 20,000   Derivative/Non-derivative trans. at $1.77 per share. 35,400
04/01/2019 5,000   Acquisition at $1.89 per share. 9,450

Officers and Executives

Dr. Jay S. Duker
President, Chief Executive Officer & Director
Mr. George O. Elston
CFO & Head-Corporate Development
Dr. Said Saim
Chief Technology Officer
Dr. Dario A. Paggiarino
Chief Medical Officer & Senior Vice President
Ms. Jennifer Leonard
Chief People Officer & Senior Vice President-IT
Mr. Scott Jones
Chief Commercial Officer & Senior Vice President
Mr. Michael C. Pine
Chief Corporate Development & Strategy Officer
Mr. Ye Liu
Director
Mr. Ron I. Honig
Secretary, Chief Legal Officer & Senior VP
Ms. Isabelle Lefebvre
Chief Regulatory Officer
Dr. Göran Albert Torstensson Ando
Non-Executive Chairman
Ms. Wendy F. DiCicco
Independent Director
Dr. Anthony P. Adamis
Independent Director
Ms. Karen L. Zaderej
Independent Director
Dr. John Barry Landis
Independent Director
Dr. David R. Guyer
Independent Director
Link to MarketWatch's Slice.